Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2018-04-03
2019-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators have formed an international and interprofessional evaluative team with experts in the field in an effort to explore interactions between survivors and THRIVE. This approach is reflective of the international ethos of SCCM and its collaboratives, with the potential to improve the generalizability of this survivorship research to different health systems.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ICU Recovery in Australian Patients
NCT02225938
MICU Recovery Clinic
NCT02560129
CharacterisatiON of carDiac funCTion in Intensive Care Unit Survivors of Sepsis.
NCT05633290
Recovery After ICU Treatment: A Prospective Cohort Study
NCT02599428
The PREDICT Study- a Registry in Critically Ill Patients to Determine Predictors of Disability Free Survival
NCT03226912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To identify elements that helped survivors in their recovery, as well as potential obstacles
2. To capture elements of survivorshop that are generalizable, regardless of participation in the THRIVE collaboratives
3. To gain knowledge to be incorporated back into the collaboratives
Patients, family members, and clinicians will be interviewed and their responses analyzed for themes of ICU recovery including elements that patients and families find helpful to recovery, barriers and facilitators to different models of post-ICU support, including peer support and post-ICU clinics, and drivers of improvement in post-ICU care. Patients, carers, and clinicians with a wide variety of survivorship experiences are encouraged to participate, including those who have participated in a THRIVE collaborative support site (peer support or clinic).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient, Carer, and Clinician Interviews
This group/cohort consists of patients who experienced critical illness and were hospitalized in an ICU setting.
Patient, Carer, and Clinician Interviews
Post-ICU follow-up interviews conducted over the phone, lasting between 30-60 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient, Carer, and Clinician Interviews
Post-ICU follow-up interviews conducted over the phone, lasting between 30-60 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who survived a critical illness, and their carers, who did not participate in a THRIVE program.
3. Clinicians directly involved in the care of ICU survivors in the outpatient setting, who have participated in a THRIVE initiative through the Society of Critical Care Medicine.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Society of Critical Care Medicine
OTHER
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carla Sevin
Assistant Professor of Medicine, Director of the ICU Recovery Center at Vanderbilt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carla M Sevin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Australian and New Zealand Intensive Care Research Centre
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
172158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.